Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Goodwill & Intangibles: 2023-2024

Historic Goodwill & Intangibles for Iovance Biotherapeutics (IOVA) over the last 2 years, with Dec 2024 value amounting to $313.1 million.

  • Iovance Biotherapeutics' Goodwill & Intangibles was N/A to $335.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $335.3 million, marking a year-over-year change of. This contributed to the annual value of $313.1 million for FY2024, which is 30.85% up from last year.
  • Latest data reveals that Iovance Biotherapeutics reported Goodwill & Intangibles of $313.1 million as of FY2024, which was up 30.85% from $239.3 million recorded in FY2023.
  • In the past 5 years, Iovance Biotherapeutics' Goodwill & Intangibles registered a high of $313.1 million during FY2024, and its lowest value of $239.3 million during FY2023.
  • Moreover, its 2-year median value for Goodwill & Intangibles was $276.2 million (2023), whereas its average is $276.2 million.
  • Data for Iovance Biotherapeutics' Goodwill & Intangibles shows a peak YoY skyrocketed of 30.85% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Iovance Biotherapeutics' Goodwill & Intangibles stood at $239.3 million in 2023, then spiked by 30.85% to $313.1 million in 2024.